Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Linda W van Laake"'
Autor:
Lian Y. Rekker, MsC, Erik Renkema, PhD, Femke Hilverda, PhD, Linda W. van Laake, MD, PhD, Pieter A. Doevendans, MD, PhD, Joost P.G. Sluijter, PhD, Pim van der Harst, MD, PhD, J. Peter van Tintelen, MD, PhD, Anneline S.J.M. te Riele, MD, PhD
Publikováno v:
Heart Rhythm O2, Vol 5, Iss 10, Pp 747-749 (2024)
Externí odkaz:
https://doaj.org/article/248d6b94c62e4290bdc75378235ba41a
Autor:
Janine C Deddens, Dries A Feyen, Peter-Paul Zwetsloot, Maike A Brans, Sailay Siddiqi, Linda W van Laake, Pieter A Doevendans, Joost P Sluijter
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173657 (2017)
BACKGROUND:Translational failure for cardiovascular disease is a substantial problem involving both high research costs and an ongoing lack of novel treatment modalities. Despite the progress already made, cell therapy for chronic heart failure in th
Externí odkaz:
https://doaj.org/article/dee237f3901c4a51bb48a9f66a2cd7b4
Autor:
Ilse R. Kelters, Devin Verbueken, Tess Beekink, Linda W. Van Laake, Joost P.G. Sluijter, Renee G.C. Maas, Jan W. Buikema
Publikováno v:
Stem Cell Research, Vol 80, Iss , Pp 103497- (2024)
A newly identified pathogenic variant (A527G) in alpha B-crystallin (αB-crystallin) has been linked to congenital cataract and young-onset dilated cardiomyopathy (DCM) within a Dutch family, although the disease mechanism remains unclear. Four human
Externí odkaz:
https://doaj.org/article/d4ed9e97ed0d47b6b666cbfe115493e0
Autor:
Lauren Dautzenberg, Linda W. van Laake, Renee C.M.A. Raijman, Geert J. Lefeber, Wilma Knol, Marish I.F. Oerlemans, Faiz Z. Ramjankhan, Susan A. Braithwaite, Mieke D.J. Nagtegaal, Marielle H. Emmelot-Vonk, Huiberdina L Koek
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 50, Iss , Pp 101318- (2024)
Background: The aim of this study was to assess the prevalence of frailty and other impairments in potential left ventricular assist device (LVAD) and heart transplantation (HTx) candidates by performing a preoperative comprehensive geriatric assessm
Externí odkaz:
https://doaj.org/article/14fdc89e8fab41f788d7832dd632a834
Autor:
Lieke Numan, Daniel Zimpfer, Osnat Itzhaki Ben Zadok, Emmeke Aarts, Michiel Morshuis, Sabina P.W. Guenther, Julia Riebandt, Dominik Wiedemann, Faiz Z. Ramjankhan, Anne‐Marie Oppelaar, Tuvia Ben‐Gal, Binyamin Ben‐Avraham, Folkert W. Asselbergs, Rene Schramm, Linda W. Van Laake
Publikováno v:
ESC Heart Failure, Vol 10, Iss 3, Pp 1656-1665 (2023)
Abstract Aims Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3). Therefore, it is important to study outcome differences bet
Externí odkaz:
https://doaj.org/article/1f408b6c2068443aa1ca498ab8aa899c
Autor:
Lieke Numan, Emmeke Aarts, Faiz Ramjankhan, Marish I. F. Oerlemans, Manon G. van der Meer, Nicolaas de Jonge, Anne‐Marie Oppelaar, Hans Kemperman, Folkert W. Asselbergs, Linda W. Van Laake
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background Soluble suppression of tumorigenicity‐2 (sST2) predicts mortality in patients with heart failure. The predictive value of sST2 in patients with a left ventricular assist device remains unknown. Therefore, we studied the relationship betw
Externí odkaz:
https://doaj.org/article/42b2e3fe935f4a04850feeaa419fd5a9
Autor:
Lieke Numan, Rene Schramm, Marish I.F.J. Oerlemans, Niels P. van derKaaij, Emmeke Aarts, Faiz Z. Ramjankhan, Anne‐Marie Oppelaar, Michiel Morshuis, Sabina P.W. Guenther, Daniel Zimpfer, Julia Riebandt, Dominik Wiedemann, Folkert W. Asselbergs, Linda W. Van Laake
Publikováno v:
ESC Heart Failure, Vol 10, Iss 4, Pp 2754-2756 (2023)
Externí odkaz:
https://doaj.org/article/3d3dfde61ef6492fb854d4874dfe2654
Autor:
Lulu Said Fundikira, Pilly Chillo, Mohamed Z. Alimohamed, Henry Mayala, Engerasiya Kifai, Geofrey M. Aloyce, Appolinary Kamuhabwa, Gideon Kwesigabo, Linda W. van Laake, Folkert W. Asselbergs
Publikováno v:
Global Heart, Vol 19, Iss 1, Pp 26-26 (2024)
Background: Non-ischemic dilated cardiomyopathy (NIDCM) is a common cause of heart failure with progressive tendency. The disease occurs in one in every 2,500 individuals in the developed world, with high morbidity and mortality. However, detailed da
Externí odkaz:
https://doaj.org/article/baab523e0c1644e499d6ee64eaf2254b
Autor:
Sandra Crnko, Markella I. Printezi, Peter-Paul M. Zwetsloot, Laurynas Leiteris, Andrew I. Lumley, Lu Zhang, Isabelle Ernens, Tijn P.J. Jansen, Lilian Homsma, Dries Feyen, Martijn van Faassen, Bastiaan C. du Pré, Carlo A.J.M. Gaillard, Hans Kemperman, Marish I.F.J. Oerlemans, Pieter A.F.M. Doevendans, Anne M. May, Nicolaas P.A. Zuithoff, Joost P.G. Sluijter, Yvan Devaux, Linda W. van Laake
Publikováno v:
EBioMedicine, Vol 91, Iss , Pp 104556- (2023)
Summary: Background: Circadian (24-h) rhythms are important regulators in physiology and disease, but systemic disease may disrupt circadian rhythmicity. Heart failure (HF) is a systemic disease affecting hormonal regulation. We investigate whether H
Externí odkaz:
https://doaj.org/article/fec2714c61d84e8a9871dbadb062fc9d
Autor:
Lauren Dautzenberg, Lieke Numan, Wilma Knol, Monica Gianoli, Manon G. van der Meer, Anne-Marie Troost-Oppelaar, Aline F. Westendorp, Marielle H. Emmelot-Vonk, Linda W. van Laake, Huiberdina L. Koek
Publikováno v:
American Heart Journal Plus, Vol 24, Iss , Pp 100233- (2022)
Background: The prevalence of (hyper)polypharmacy in patients on left ventricular assist device (LVAD) support and its effect on clinical outcomeis unknown. Therefore, we aimed to determine the prevalence of (hyper)polypharmacy in LVAD patients and e
Externí odkaz:
https://doaj.org/article/630e8a9ebd7b4b5f87003ac2c53f7cd4